Affiliations 

  • 1 K Ramanathan, KMN, AM (Mal), BDS (S'pore), COP (Lond), FDSRCS (Edin), FDSRCS (Eng), MIADR, CMIAOP, FICD, MICOI, MAAOM, (USA), MAAOP (USA). Consultant Stomatologist & Head, Department of Stomatology, Institute for Medical Research, Kuala Lumpur. 03-19, Malaysia
  • 2 Peace Indrani Chelvanayagam, BDS (Mal). Dental Officer, Department of Stomatology, Institute for Medical Research, Kuala Lumpur. 03-19, Malaysia
  • 3 Ng Kok Han, BDS (Mal). Dental Officer, Department of Stomatology, Institute for Medical Research, Kuala Lumpur. 03-19, Malaysia
  • 4 Jayanthi Ramanathan, BDS, PhD. Visiting Fellow from Dental School, Faculty of Medicine, Unversity of Peradeniya, Sri Lanka
Med J Malaysia, 1982 Mar;37(1):18-24.
PMID: 7121342

Abstract

Ameloblastomas formed 1.1 percent of all oral pathology cases reported. The race, sex and age group distribution of 133 cases are shown. The peak age incidence (70.6 percent) was between 11-40 years. The mandible was involved 9 times more commonly than the maxilla. The anatomical sites of distribution, clinical and radiological features, histological variants and their correlation are discussed. Twenty two patients (15 percent) had ameloblastomas associated with a dentigerous cyst and/or unerupted teeth. Ameloblastomas with the above clinical features represented a much less aggressive form of neoplasm. The authors could not correlate histological variants of ameloblastoma with recurrence rates. The various treatment methods and the respective recurrence rates are outlined. Radiotherapy and marsupialization as treatment of ameloblastoma are not recommended. The indications for enucleation curettage, resection en bloc, segmental resection and hemimandibulectomy
are emphasized. Ameloblastomas involving the maxilla should be treated by complete removal en bloc with a margin of normal tissue. Since ameloblastoma has the capacity to recur after several years of apparent cure patients who have been treated for ameloblastoma must be followed up periodically during their life time. So far no case of ameloblastoma in this study has shown evidence
ofmetastasis.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.